The phenotypic spectrum of progressive supranuclear palsy

被引:64
|
作者
Respondek, G. [1 ,2 ]
Hoeglinger, G. U. [1 ,2 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany
[2] DZNE, D-81677 Munich, Germany
关键词
Phenotypes; Progressive supranuclear palsy PSP; Tauopathy; RICHARDSON-OLSZEWSKI-SYNDROME; CLINICAL PHENOTYPE; PURE AKINESIA; PSP; DEGENERATION; DIAGNOSIS; FEATURES; APRAXIA; DISEASE; SPEECH;
D O I
10.1016/j.parkreldis.2015.09.041
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Traditionally, the clinical picture of progressive supranuclear palsy (PSP) was defined by early postural instability with falls, supranuclear vertical gaze palsy, symmetric akinesia and rigidity, frontal and subcortical dementia, and pseudobulbar palsy, leading to death after a mean disease duration of approximately six years. A definite diagnosis of PSP depends on neuropathological confirmation. In recent years, clinico-pathological studies have drawn attention to various "atypical" clinical manifestations of PSP. In these, a clinical diagnosis of PSP is delayed or never accomplished. Comprehensive understanding of the natural history of PSP is required to permit an early and accurate diagnosis. Based on current evidence, this review provides an update on the clinical spectrum of PSP. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S34 / S36
页数:3
相关论文
共 50 条
  • [1] Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect
    Nasri, Amina
    Sghaier, Ikram
    Neji, Anis
    Gharbi, Alya
    Abida, Youssef
    Mrabet, Saloua
    Gargouri, Amina
    Ben Djebara, Mouna
    Kacem, Imen
    Gouider, Riadh
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (02) : 158 - 170
  • [2] Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum
    Ali, Farwa
    Clark, Heather
    Machulda, Mary
    Senjem, Matthew L.
    Lowe, Val J.
    Jack Jr, Clifford R.
    Josephs, Keith A.
    Whitwell, Jennifer
    Botha, Hugo
    BRAIN COMMUNICATIONS, 2024, 6 (04)
  • [3] The Phenotypic Spectrum of Progressive Supranuclear Palsy: A Retrospective Multicenter Study of 100 Definite Cases
    Respondek, Gesine
    Stamelou, Maria
    Kurz, Carolin
    Ferguson, Leslie W.
    Rajput, Alexander
    Chiu, Wan Zheng
    van Swieten, John C.
    Troakes, Claire
    al Sarraj, Safa
    Gelpi, Ellen
    Gaig, Carles
    Tolosa, Eduardo
    Oertel, Wolfgang H.
    Giese, Armin
    Roeber, Sigrun
    Arzberger, Thomas
    Wagenpfeil, Stefan
    Hoeglinger, Guenter U.
    MOVEMENT DISORDERS, 2014, 29 (14) : 1758 - 1766
  • [4] An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant
    Whitwell, Jennifer L.
    Stevens, Chase A.
    Duffy, Joseph R.
    Clark, Heather M.
    Machulda, Mary M.
    Strand, Edythe A.
    Martin, Peter R.
    Utianski, Rene L.
    Botha, Hugo
    Spychalla, Anthony J.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Jack, Clifford R., Jr.
    Ali, Farwa
    Hassan, Anhar
    Josephs, Keith A.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (06): : 452 - 461
  • [5] Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology
    Whitwell, J. L.
    Jack, C. R., Jr.
    Parisi, J. E.
    Gunter, J. L.
    Weigand, S. D.
    Boeve, B. F.
    Ahlskog, J. E.
    Petersen, R. C.
    Dickson, D. W.
    Josephs, K. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (10) : 1417 - 1422
  • [6] Phenotypic Variants of Patients with Progressive Supranuclear Palsy
    Gultekin, Murat
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2020, 57 (01): : 61 - 64
  • [7] Dysphagia in Progressive Supranuclear Palsy
    Clark, Heather M.
    Stierwalt, Julie A. G.
    Tosakulwong, Nirubol
    Botha, Hugo
    Ali, Farwa
    Whitwell, Jennifer L.
    Josephs, Keith A.
    DYSPHAGIA, 2020, 35 (04) : 667 - 676
  • [8] Immunotherapy in progressive supranuclear palsy
    Vaswani, Pavan A.
    Olsen, Abby L.
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (04) : 527 - 533
  • [9] Pathological and Clinical Spectrum of Progressive Supranuclear Palsy: With Special Reference to Astrocytic Tau Pathology
    Yokoyama, Yuichi
    Toyoshima, Yasuko
    Shiga, Atsushi
    Tada, Mari
    Kitamura, Hideaki
    Hasegawa, Kazuko
    Onodera, Osamu
    Ikeuchi, Takeshi
    Someya, Toshiyuki
    Nishizawa, Masatoyo
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    BRAIN PATHOLOGY, 2016, 26 (02) : 155 - 166
  • [10] Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants
    Black, Jack A.
    Pham, Nha Trang Thu
    Ali, Farwa
    Machulda, Mary M.
    Lowe, Val J.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    JOURNAL OF NEUROLOGY, 2024, 271 (07) : 4267 - 4280